Organigram Global Inc.
OGI
Positions held
Your positionsOGI isn't in your positions.
Add it to see shares, cost, and P&L here.
Fundamentals
| Market cap | $137.10M | Enterprise value | $225.15M | Trailing P/E | 2.21 | Forward P/E | 39.63 |
| PEG | — | Price / book | 0.36 | Beta | 1.91 | Dividend yield | 0.00% |
| Revenue growth | 49.4% | Earnings growth | — | Gross margin | 36.5% | Operating margin | 5.0% |
| Profit margin | 28.0% | ROE | 17.6% | ROA | -0.6% | Debt / equity | 0.06 |
| Current ratio | 2.61 | Free cash flow | -$1.25M | Analyst recommendation | buy | Mean target | — |
| 52w high | $2.24 | 52w low | $0.85 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|---|---|
| Revenue | $106M | $59.8M | $63.5M | $80.1M | $70.8M | — |
| Op margin | 5.0% | -16.4% | -5.4% | 1.5% | -3.0% | — |
| Net income | $106M | -$0.9M | $20.0M | -$38.0M | -$6.3M | — |
| Gross margin | 39.2% | 27.4% | 36.7% | 39.8% | 36.9% | — |
| Gross profit | $41.4M | $16.4M | $23.3M | $31.8M | $26.1M | — |
| Operating income | $5.3M | -$9.8M | -$3.4M | $1.2M | -$2.1M | — |
- Revenue +77% vs prior quarter ($106M vs $60M).
- Gross margin 39.2% (was 27.4% prior quarter).
- Operating margin expanded to 5%.
Yearly (6y)
| 2025 | 2024 | 2022 | |
|---|---|---|---|
| Revenue | $259M | $160M | $146M |
| Op margin | -5.9% | -21.7% | -26.6% |
| Net income | -$24.8M | -$45.4M | -$14.3M |
| Gross margin | 34.8% | 29.7% | 21.7% |
| Gross profit | $90.2M | $47.5M | $31.6M |
| Operating income | -$15.3M | -$34.8M | -$38.8M |
Headlines — positive tone
• [OK · fundamentals] Organigram Global Inc (OGI) (Q3 2026) Earnings Call Highlights: Record Revenue and EBITDA ...
News
2026-09-30 · Organigram Global Targets Profitable Growth With Canada Focus and German Expansion
2026-09-30 · Organigram Global to Premiere The 2026 OG Investor Session Today at 4:00 p.m. ET on X
2026-09-02 · Organigram Global to Host 2026 OG Investor Session
2026-09-01 · Cannara Biotech Appoints Nicholas Fozard as CFO
2026-08-20 · Organigram Global Accelerates Integration of Sanity Group Under Unified Global Operating Structure
2026-08-18 · Organigram (OGI) Q3 2026 Earnings Call Transcript
2026-08-17 · Weekly Roundup on the Cannabis Sector & Psychedelic Sector
2026-08-12 · Organigram Global Inc. Q3 2026 Earnings Call Summary
2026-08-11 · Organigram Global Inc (OGI) (Q3 2026) Earnings Call Highlights: Record Revenue and EBITDA ...
2026-08-11 · OrganiGram (OGI) Reports Q3 Loss, Beats Revenue Estimates
2026-08-11 · Organigram Global Q3 Earnings Call Highlights
2026-08-11 · Organigram Global Swings to Net Income in Q3 Fiscal 2026, Net Revenue Rises
Price (daily)
Full chart · RSI · MACD · patterns